Apolipoprotein L1 (APOL1), the best-known gene, imparts a greatly increased risk of adult-onset FSGS and is associated with lower kidney function, more glomerulosclerosis and interstitial fibrosis, and greater propensity to progress to ESRD (5). This evidence concerns the gene APOL1 and focal segmental glomerulosclerosis.